{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:04Z","timestamp":1750538404706,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 41-year-old woman received stem cell transplant due to acute myeloid leukemia. Six months after the stem cell transplant, the patient experienced monomorphic PTLD (posttransplant lymphoproliferative disorder) and underwent chemotherapy. Postchemotherapy PET\/CT did not show any abnormal <jats:sup>18<\/jats:sup>F-FDG accumulation in the scanned body, including brain. Four months later, she presented with nausea and vomiting. Brain MRI showed a lesion in the right temporal lobe. In addition to the abnormal <jats:sup>18<\/jats:sup>F-FDG accumulation in the brain, no other abnormal foci were noted in the torso PET\/CT. Biopsy pathology confirmed the diagnosis of monomorphic PTLD.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004337","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T23:01:04Z","timestamp":1657839664000},"page":"1007-1009","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"47","author":[{"given":"Lijuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pbc.23134","article-title":"Sustained response to intrathecal rituximab in EBV associated post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant","volume":"58","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e13302","DOI":"10.1111\/petr.13302","article-title":"Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder","volume":"22","year":"2018","journal-title":"Pediatr Transplant"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bmt.1705575","article-title":"Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR","volume":"39","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2967\/jnumed.119.239624","article-title":"18F-FDG PET\/CT in the diagnostic and treatment evaluation of pediatric posttransplant lymphoproliferative disorders","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/RLU.0000000000001876","article-title":"18F-FDG PET for detection of primary tracheobronchial T-\/natural killer-cell-derived posttransplant lymphoproliferative disorder after lung transplantation","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/RLU.0000000000002027","article-title":"FDG PET\/CT findings of polymorphic posttransplant lymphoproliferative disorders in a transplanted kidney","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/RLU.0000000000000866","article-title":"FDG PET\/CT findings of the recurrent posttransplantation lymphoproliferative disorder in a pediatric liver transplant recipient with right leg pain as the only complaint","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/TP.0000000000002006","article-title":"End-of-treatment positron emission tomography after uniform first-line therapy of B-cell posttransplant lymphoproliferative disorder identifies patients at low risk of relapse in the prospective German PTLD registry","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/RLU.0000000000003524","article-title":"Primary cutaneous natural killer\/T-cell lymphoma: a posttransplant lymphoproliferative disorder demonstrated by 18F-FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/RLU.0000000000003413","article-title":"Diffuse subcutaneous metabolic activity in post bone marrow transplant Hodgkin lymphoma","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","first-page":"136","article-title":"The role of 18F-FDG PET\/CT in the evaluation of pediatric transplant patients","volume":"18","year":"2015","journal-title":"Hell J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:24Z","timestamp":1750536204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004337","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}